Pascale Witz

Pascale Witz is a declared insider at 4 companies (board member); the most frequent names are Revvity, Inc., Horizon Therapeutics Public Ltd Co and Regulus Therapeutics Inc. Between 15 November 2017 and 25 June 2025, the trades on record add up to 38 filings.

The open-market side counts 1 purchase for €29k alongside 2 sales for €247k. Taken together, the sales exceed the purchases by €218k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 25 share grants and 7 option exercises.

The record was last updated on 27 June 2025 with a transaction in Regulus Therapeutics Inc. The last purchase on record was published on 8 May 2019, which is 2,722 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.